2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Richard Stock, MD, a professor of radiation oncology at the Icahn School of Medicine at Mount Sinai Hospital, talks about brachytherapy and its benefits for patients with prostate cancer.
Richard Stock, MD, a professor of radiation oncology at the Icahn School of Medicine at Mount Sinai Hospital, talks about brachytherapy and its benefits for patients with prostate cancer.
Brachytherapy, which involves placing radioactive pellets in or near the tumor, limits the dose of radiation only to the prostate by delivering a low dose from within the body over several months.
The prostate receives a high amount of radiation therapy biologically, while keeping the radiation dose to the rectal and bladder very low.
Related Content: